CARLOS FIGAROLA: Open Payments
NPI 1306999768 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 10 payments from 3 companies in 2025. Trend: 2023 $396 · 2024 $414 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $548 |
| Teva Pharmaceuticals USA, Inc. | 2 | $143 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: CAPLYTA, AUSTEDO XR, REXULTI.
Industry payments across NJ — which companies pay providers there.
